Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems.
about
Current approaches to enhance CNS delivery of drugs across the brain barriersFree diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculationsSingle compartment drug delivery.Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.Computer-aided retrometabolic drug design: soft drugs.Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles.Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.CNS drug delivery: opioid peptides and the blood-brain barrierInterpretation of antibiotic concentration ratios measured in epithelial lining fluid.Prodrug approaches for CNS deliveryPolyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Designing prodrugs for the treatment of Parkinson's disease.Chemical delivery systems and soft drugs: Retrometabolic approaches of drug design.Recent prospective of surface engineered Nanoparticles in the management of Neurodegenerative disorders.Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios.Pro-2-PAM therapy for central and peripheral cholinesterases.Conditional ablation and recovery of forebrain neurogenesis in the mouse.Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brainA tryptamine analog with high affinity to the heart tissues is a potential antiarrhythmic agent.Nitroxyl radicals as low toxic spin-labels for non-invasive magnetic resonance imaging of blood-brain barrier permeability for conventional therapeutics.Toxicological evaluation in silico and in vivo of secondary metabolites of Cissampelos sympodialis in Mus musculus mice following inhalation.Design and physicochemical characterization of poly(amidoamine) nanoparticles and the toxicological evaluation in human endothelial cells: applications to peptide delivery to the brain.Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.LAT1-mediated prodrug uptake: a way to breach the blood-brain barrier?Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease.Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis.Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.
P2860
Q30437835-78200D5F-0E1D-4EB4-B1AA-417D75E55976Q34186724-9F91A82D-561E-4263-9D7F-344F1175B4E9Q34263907-C198A0CC-A311-443B-81E6-E7B98129D9E4Q34470807-CFE804E6-1CFE-4F36-B8CA-85B9B48374D2Q34556508-8F4A3527-68E3-43F7-B63B-F50768B469CDQ34619242-DAD50C01-A9A7-4D3F-9AD2-7C0E223E579BQ34701454-12C49DB0-D998-48D5-8D17-257BCBB1C259Q36043183-65511ACA-761D-4EAF-B85C-70E9A05ED81CQ36439195-54A0B980-26D2-4A3B-8C4A-3656A95C4107Q36936597-E02E7F2D-4C65-4071-9375-8F447CA45A38Q37150860-68D48E82-F945-432F-8B88-1B7FEB7FDA5FQ37668360-ABBF6BCF-F8F4-4C16-BE81-71812DB38AD0Q37995554-C11330DA-8770-4FAF-A19F-75F67B76957DQ38001793-7A03B482-18FF-4776-B898-E307BCE62218Q38243778-B0287D38-DCB5-4BAD-B501-308A4EB9D593Q38536735-6FC9DF30-12D4-492C-AEF6-53B4AB02882CQ38969029-C02D4CA4-9D14-45B2-A0B2-634D4AD0939FQ39444327-39A9F802-FD47-4A93-86D8-80AC54D09D06Q41240603-5AE267A9-F089-40B0-B1D8-36A0FFB33A29Q41779451-88B74112-2CB5-47C6-9573-1F5055A2DF21Q42090018-49A86D69-7628-40B3-A495-117D351D0E12Q43655098-055F676D-059B-4FE4-A648-F8314F9115FCQ46198827-0899F1D2-DF8B-4120-9864-8A00CF0AA4D0Q46249106-C0D5DC79-A713-448B-99B9-55A2E2EFA7ECQ46626681-1B704495-1B83-44E3-896E-9772ED27CCAFQ47200107-06DA2A84-AEED-4F66-A95C-61E908861C4AQ48148305-307AF69C-6164-44F1-9F0E-C5B1353313B0Q48895773-08D23E0A-DFAB-4C5C-9C29-1A5B8D987AB3Q48895814-08F9ABD7-F84F-4E25-A155-697EB5244E91Q49103683-07725A98-781D-424F-9AE0-83ABD3A00D81
P2860
Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Recent advances in the brain t ...... by chemical delivery systems.
@ast
Recent advances in the brain t ...... by chemical delivery systems.
@en
type
label
Recent advances in the brain t ...... by chemical delivery systems.
@ast
Recent advances in the brain t ...... by chemical delivery systems.
@en
prefLabel
Recent advances in the brain t ...... by chemical delivery systems.
@ast
Recent advances in the brain t ...... by chemical delivery systems.
@en
P1476
Recent advances in the brain t ...... by chemical delivery systems.
@en
P2093
P304
P356
10.1016/S0169-409X(98)00090-8
P407
P577
1999-04-01T00:00:00Z